We like shares trading at ~8x CY27E EV/FCF (~16x on GAAP EV/FCF) for an accelerating ARR growth story, with incremental new bookings increasingly driven by IAM. With a path to sustained double-digit top-line growth on the table, we view the increased R&D investment positively and look forward to additional product updates at DOCU's Momentum conference on May 20-21.